A prospective study to establish a new-onset diabetes cohort: From the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer

Anirban Maitra, Ayush Sharma, Randall E. Brand, Stephen K. Van Den Eeden, William E. Fisher, Phil A. Hart, Steven J. Hughes, Kieren Mather, Stephen J. Pandol, Walter G. Park, Ziding Feng, Jose Serrano, Jo Ann S. Rinaudo, Sudhir Srivastava, Suresh T. Chari

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The National Cancer Institute and the National Institute for Diabetes and Digestive and Kidney Diseases initiated the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) in 2015 (the CPDPC's origin, structure, governance, and research objectives are described in another article in this journal). One of the key objectives of CPDPC is to assemble a cohort of 10,000 subjects 50 years or older with new-onset diabetes, called the NOD cohort. Using a define, enrich, and find early detection approach, the aims of the NOD study are to (a) estimate the 3-year probability of pancreatic ductal adenocarcinoma (PDAC) in NOD (define), (b) establish a biobank of clinically annotated biospecimens from presymptomatic PDAC and control new-onset type 2 diabetes mellitus subjects, (c) conduct phase 3 validation studies of promising biomarkers for identification of incident PDAC in NOD patients (enrich), and (d) provide a platform for development of a future interventional screening protocol for early detection of PDAC in patients with NOD that incorporates imaging studies and/or clinical algorithms (find). It is expected that 85 to 100 incidences of PDAC will be diagnosed during the study period in this cohort of 10,000 patients.

Original languageEnglish (US)
Pages (from-to)1244-1248
Number of pages5
JournalPancreas
Volume47
Issue number10
DOIs
StatePublished - Nov 1 2018

Fingerprint

Chronic Pancreatitis
Pancreatic Neoplasms
Adenocarcinoma
Prospective Studies
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
National Cancer Institute (U.S.)
Validation Studies
Type 2 Diabetes Mellitus
Biomarkers
Incidence
Research

Keywords

  • biomarker
  • diabetes
  • high-risk group
  • screening
  • sporadic pancreatic cancer

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Cite this

Maitra, A., Sharma, A., Brand, R. E., Van Den Eeden, S. K., Fisher, W. E., Hart, P. A., ... Chari, S. T. (2018). A prospective study to establish a new-onset diabetes cohort: From the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. Pancreas, 47(10), 1244-1248. https://doi.org/10.1097/MPA.0000000000001169

A prospective study to establish a new-onset diabetes cohort : From the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. / Maitra, Anirban; Sharma, Ayush; Brand, Randall E.; Van Den Eeden, Stephen K.; Fisher, William E.; Hart, Phil A.; Hughes, Steven J.; Mather, Kieren; Pandol, Stephen J.; Park, Walter G.; Feng, Ziding; Serrano, Jose; Rinaudo, Jo Ann S.; Srivastava, Sudhir; Chari, Suresh T.

In: Pancreas, Vol. 47, No. 10, 01.11.2018, p. 1244-1248.

Research output: Contribution to journalArticle

Maitra, A, Sharma, A, Brand, RE, Van Den Eeden, SK, Fisher, WE, Hart, PA, Hughes, SJ, Mather, K, Pandol, SJ, Park, WG, Feng, Z, Serrano, J, Rinaudo, JAS, Srivastava, S & Chari, ST 2018, 'A prospective study to establish a new-onset diabetes cohort: From the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer', Pancreas, vol. 47, no. 10, pp. 1244-1248. https://doi.org/10.1097/MPA.0000000000001169
Maitra, Anirban ; Sharma, Ayush ; Brand, Randall E. ; Van Den Eeden, Stephen K. ; Fisher, William E. ; Hart, Phil A. ; Hughes, Steven J. ; Mather, Kieren ; Pandol, Stephen J. ; Park, Walter G. ; Feng, Ziding ; Serrano, Jose ; Rinaudo, Jo Ann S. ; Srivastava, Sudhir ; Chari, Suresh T. / A prospective study to establish a new-onset diabetes cohort : From the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer. In: Pancreas. 2018 ; Vol. 47, No. 10. pp. 1244-1248.
@article{e199b19b1ee8497aaeb513d6f1afd834,
title = "A prospective study to establish a new-onset diabetes cohort: From the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer",
abstract = "The National Cancer Institute and the National Institute for Diabetes and Digestive and Kidney Diseases initiated the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) in 2015 (the CPDPC's origin, structure, governance, and research objectives are described in another article in this journal). One of the key objectives of CPDPC is to assemble a cohort of 10,000 subjects 50 years or older with new-onset diabetes, called the NOD cohort. Using a define, enrich, and find early detection approach, the aims of the NOD study are to (a) estimate the 3-year probability of pancreatic ductal adenocarcinoma (PDAC) in NOD (define), (b) establish a biobank of clinically annotated biospecimens from presymptomatic PDAC and control new-onset type 2 diabetes mellitus subjects, (c) conduct phase 3 validation studies of promising biomarkers for identification of incident PDAC in NOD patients (enrich), and (d) provide a platform for development of a future interventional screening protocol for early detection of PDAC in patients with NOD that incorporates imaging studies and/or clinical algorithms (find). It is expected that 85 to 100 incidences of PDAC will be diagnosed during the study period in this cohort of 10,000 patients.",
keywords = "biomarker, diabetes, high-risk group, screening, sporadic pancreatic cancer",
author = "Anirban Maitra and Ayush Sharma and Brand, {Randall E.} and {Van Den Eeden}, {Stephen K.} and Fisher, {William E.} and Hart, {Phil A.} and Hughes, {Steven J.} and Kieren Mather and Pandol, {Stephen J.} and Park, {Walter G.} and Ziding Feng and Jose Serrano and Rinaudo, {Jo Ann S.} and Sudhir Srivastava and Chari, {Suresh T.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1097/MPA.0000000000001169",
language = "English (US)",
volume = "47",
pages = "1244--1248",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - A prospective study to establish a new-onset diabetes cohort

T2 - From the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer

AU - Maitra, Anirban

AU - Sharma, Ayush

AU - Brand, Randall E.

AU - Van Den Eeden, Stephen K.

AU - Fisher, William E.

AU - Hart, Phil A.

AU - Hughes, Steven J.

AU - Mather, Kieren

AU - Pandol, Stephen J.

AU - Park, Walter G.

AU - Feng, Ziding

AU - Serrano, Jose

AU - Rinaudo, Jo Ann S.

AU - Srivastava, Sudhir

AU - Chari, Suresh T.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - The National Cancer Institute and the National Institute for Diabetes and Digestive and Kidney Diseases initiated the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) in 2015 (the CPDPC's origin, structure, governance, and research objectives are described in another article in this journal). One of the key objectives of CPDPC is to assemble a cohort of 10,000 subjects 50 years or older with new-onset diabetes, called the NOD cohort. Using a define, enrich, and find early detection approach, the aims of the NOD study are to (a) estimate the 3-year probability of pancreatic ductal adenocarcinoma (PDAC) in NOD (define), (b) establish a biobank of clinically annotated biospecimens from presymptomatic PDAC and control new-onset type 2 diabetes mellitus subjects, (c) conduct phase 3 validation studies of promising biomarkers for identification of incident PDAC in NOD patients (enrich), and (d) provide a platform for development of a future interventional screening protocol for early detection of PDAC in patients with NOD that incorporates imaging studies and/or clinical algorithms (find). It is expected that 85 to 100 incidences of PDAC will be diagnosed during the study period in this cohort of 10,000 patients.

AB - The National Cancer Institute and the National Institute for Diabetes and Digestive and Kidney Diseases initiated the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) in 2015 (the CPDPC's origin, structure, governance, and research objectives are described in another article in this journal). One of the key objectives of CPDPC is to assemble a cohort of 10,000 subjects 50 years or older with new-onset diabetes, called the NOD cohort. Using a define, enrich, and find early detection approach, the aims of the NOD study are to (a) estimate the 3-year probability of pancreatic ductal adenocarcinoma (PDAC) in NOD (define), (b) establish a biobank of clinically annotated biospecimens from presymptomatic PDAC and control new-onset type 2 diabetes mellitus subjects, (c) conduct phase 3 validation studies of promising biomarkers for identification of incident PDAC in NOD patients (enrich), and (d) provide a platform for development of a future interventional screening protocol for early detection of PDAC in patients with NOD that incorporates imaging studies and/or clinical algorithms (find). It is expected that 85 to 100 incidences of PDAC will be diagnosed during the study period in this cohort of 10,000 patients.

KW - biomarker

KW - diabetes

KW - high-risk group

KW - screening

KW - sporadic pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=85055078761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055078761&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000001169

DO - 10.1097/MPA.0000000000001169

M3 - Article

C2 - 30325864

AN - SCOPUS:85055078761

VL - 47

SP - 1244

EP - 1248

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 10

ER -